Safety and efficacy in ablation of premature ventricular contraction: data from the German ablation registry

Clinical Research in Cardiology

Volumn 106, Issue 1, 2017, Pages 49-57

  Fichtner, S ^a   Senges, J ^b   Hochadel, M ^b   Tilz, R ^c   Willems, S ^d   Eckardt, L ^e   Deneke, T ^f   Lewalter, T ^g   Dorwarth, U ^h   Reithmann, C ⁱ   Brachmann, J ^j   Steinbeck, G ^k   Kaab S ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Foundation Stiftung Institut für Herzinfarktforschung   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^f Institut für Diagnostische und Interventionelle Radiologie   (Germany)

^g Internistische Klinik Dr Muller   (Germany)

^h Chirurgische Klinik Munchen Bogenhausen   (Germany)

ⁱ Abteilung für Handchirurgie   (Germany)

^j KLINIKUM COBURG   (Germany)

^k Zentrum für Kardiologie und Angiologie am Klinikum Starnberg   (Germany)

more..

Author keywords

Ablation; Left ventricular outflow tract; Premature ventricular contraction; PVC; Registry; Right ventricular outflow tract

Indexed keywords

ANTIARRHYTHMIC AGENT;

ABLATION THERAPY; ACUTE HEART INFARCTION; ADULT; AGED; ANEURYSM; ANTIARRHYTHMIC ACTIVITY; ARTICLE; BLEEDING; CARDIOMYOPATHY; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY DISEASE; DEATH; DISEASE REGISTRY; FAINTNESS; FEMALE; GERMANY; HEART DISEASE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PALPITATION; HEART RIGHT VENTRICLE OUTFLOW TRACT; HEART VENTRICLE EXTRASYSTOLE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; PERICARDIAL EFFUSION; PNEUMOTHORAX; ADVERSE EFFECTS; CATHETER ABLATION; CLINICAL TRIAL; ELECTROCARDIOGRAPHY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATIONS; REGISTER; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME; VENTRICULAR PREMATURE COMPLEXES;

ADULT; AGED; CATHETER ABLATION; ELECTROCARDIOGRAPHY; FEMALE; GERMANY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; REGISTRIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR PREMATURE COMPLEXES;

EID: 84982836754     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-016-1022-9     Document Type: Article

References (15)

1. Dukes JW, Dewland TA, Vittinghoff E et al (2015) Ventricular ectopy as a predictor of heart failure and death. J Am Coll Cardiol 66:101–109. doi:10.1016/j.jacc.2015.04.062
2. Penela D, Taxis CV, Aguinaga L et al (2013) Neurohormonal, structural, and functional recovery pattern after premature ventricular complex ablation is independent of structural heart disease status in patients with depressed left ventricular ejection fraction: a prospective multicenter study. J Am Coll Cardiol 62:1195–1202. doi:10.1016/j.jacc.2013.06.012
3. Yokokawa M, Good E, Crawford T et al (2013) Recovery from left ventricular dysfunction after ablation of frequent premature ventricular complexes. Heart Rhythm 10:172–175. doi:10.1016/j.hrthm.2012.10.011
4. Bogun F, Crawford T, Reich S et al (2007) Radiofrequency ablation of frequent, idiopathic premature ventricular complexes: comparison with a control group without intervention. Heart Rhythm 4:863–867. doi:10.1016/j.hrthm.2007.03.003
5. Ling Z, Liu Z, Su L et al (2014) Radiofrequency ablation versus antiarrhythmic medication for treatment of ventricular premature beats from the right ventricular outflow tract: prospective randomized study. Circ Arrhythmia Electrophysiol 7:237–243. doi:10.1161/CIRCEP.113.000805
6. Zhong L, Lee YH, Huang XM et al (2014) Relative efficacy of catheter ablation vs antiarrhythmic drugs in treating premature ventricular contractions: a single-center retrospective study. Heart Rhythm 11:187–193. doi:10.1016/j.hrthm.2013.10.033
7. Aliot EM, Stevenson WG, Almendral-Garrote JM et al (2009) EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); i. Heart Rhythm 6:886–933. doi:10.1016/j.hrthm.2009.04.030
8. Chun KR, Schmidt B, Kuck KH et al (2013) Catheter ablation of atrial fibrillation in the young: insights from the German Ablation Registry. Clin Res Cardiol 102:459–468. doi:10.1007/s00392-013-0553-6
9. Latchamsetty R, Yokokawa M, Morady F et al (2015) Multicenter outcomes for catheter ablation of idiopathic premature ventricular complexes. JACCCEP 1:116–123. doi:10.1016/j.jacep.2015.04.005
10. Zang M, Zhang T, Mao J et al (2014) Beneficial effects of catheter ablation of frequent premature ventricular complexes on left ventricular function. Heart 100:787–793. doi:10.1136/heartjnl-2013-305175
11. Kamioka M, Mathew S, Lin T et al (2015) Electrophysiological and electrocardiographic predictors of ventricular arrhythmias originating from the left ventricular outflow tract within and below the coronary sinus cusps. Clin Res Cardiol 104:544–554. doi:10.1007/s00392-015-0817-4
12. Baser K, Bas HD, Yokokawa M et al (2014) Infrequent intraprocedural premature ventricular complexes: implications for ablation outcome. J Cardiovasc Electrophysiol 25:1088–1092. doi:10.1111/jce.12454
13. Pytkowski M, Maciag A, Jankowska A et al (2012) Quality of life improvement after radiofrequency catheter ablation of outflow tract ventricular arrhythmias in patients with structurally normal heart. Acta Cardiol 67:153–159
14. Echt DS, Liebson PR, Mitchell LB et al (1991) Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med. doi:10.1056/NEJM199103213241201
15. Priori SG, BlomstroLundqvist C, Mazzanti A, Bloma N, Borggrefe M, Camm J et al (2015) 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. doi:10.1093/europace/eul108